Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure

New England Journal of Medicine

Volumn 340, Issue 17, 1999, Pages 1321-1328

  Ligtenberg, Gerry ^a   Blankestijn, Peter J ^a   Oey, P Liam ^a   Klein, Inge H H ^a   Dijkhorst Oei, Lioe Ting ^a   Boomsma, Frans ^b   Wieneke, George H ^a   Van Huffelen, Alexander C ^a   Koomans, Hein A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; ENALAPRIL;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HUMAN; KIDNEY BLOOD VESSEL; KIDNEY INNERVATION; MALE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SYMPATHETIC NERVE; SYMPATHETIC TONE;

AMLODIPINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BAROREFLEX; CALCIUM CHANNEL BLOCKERS; ENALAPRIL; FEMALE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MUSCLES; REFERENCE VALUES; RENIN; SYMPATHETIC NERVOUS SYSTEM;

EID: 0033614449     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199904293401704     Document Type: Article

References (33)

1. Esler M, Jennings G, Biviano B, Lambert G, Hasking G. Mechanism of elevated plasma noradrenaline in the course of essential hypertension. J Cardiovasc Pharmacol 1986;8:Suppl 5:S39-S43.
2. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension 1989;14:177-83.
3. Matsukawa T, Mano T, Gotoh E, Ishii M. Elevated sympathetic nerve activity in patients with accelerated essential hypertension. J Clin Invest 1993;92:25-8.
4. Converse RL Jr, Jacobsen TN, Toto RD, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992;327:1912-8.
5. Frolich ED, Apstein C, Chobanian AV, et al. The heart in hypertension. N Engl J Med 1992;327:998-1008. [Erratum, N Engl J Med 1992;327: 1768.]
6. Kelm M, Schafer S, Mingers S, et al. Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients. J Hypertens 1996;14:1357-64.
7. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engi J Med 1984;311:819-23.
8. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990;82:1730-6.
9. Giannattasio C, Cattaneo BM, Omboni S, et al. Sympathomoderating influence of benazepril in essential hypertension. J Hypertens 1992;10: 373-8.
10. Davis D, Baily R, Zelis R. Abnormalities in systemic norepinephrine kinetics in human congestive heart failure. Am J Physiol 1988;254:E760-E766.
11. Laederach K, Weidmann P. Plasma and urinary catecholamines as related to renal function in man. Kidney Int 1987;31:107-11.
12. Grassi G, Bolla G, Seravalle G, Turri C, Lanfranchi A, Mancia G. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci (Colch) 1997;92: 2859.
13. Vallbo AB, Hagbarth KE, Torebjork HE, Wallin BG. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 1979;59:919-57.
14. Wallin BG, Burke D, Gandevia SC. Coherence between the sympathetic drives to relaxed and contracting muscles of different limbs of human subjects. J Physiol (Lond) 1992;455:219-33.
15. Vissing SF, Scherrer U, Victor RG. Relation between sympathetic outflow and vascular resistance in the calf during perturbations in central venous pressure: evidence for cardiopulmonary afferent regulation of calf vascular resistance in humans. Circ Res 1989;65:1710-7.
16. Ferguson DW, Hayes DW. Nifedipine potentiates cardiopulmonary baroreflex control of sympathetic nerve activity in healthy humans: direct evidence from microneurographic studies. Circulation 1989;80:285-98.
17. Noll G, Wenzel RR, de Marchi S, Shaw S, Luscher TF. Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers. Circulation 1997;95:2286-92.
18. Dibner-Dunlap ME, Smith ML, Kinugawa T, Thames MD. Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. J Am Coll Cardiol 1996;27: 358-64.
19. Grassi G, Cattaneo BM, Seravalle G, et al. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation 1997;96:1173-9.
20. Ligtenberg G, Blankestijn PJ, Oey PL, Wieneke GH, van Huffelen AC, Koomans HA. Cold stress provokes sympathoinhibitory presyncope in healthy subjects and hemodialysis patients with low cardiac output. Circulation 1997;95:2271-6.
21. Snel YEM, Brummer R-JM, Bol E, et al. Direct assessment of extracellular water volume by the bromide-dilution method in growth hormone-deficient adults. Eur J Clin Invest 1995;25:708-14.
22. Boer P. Estimated lean body mass as an index for normalization of body fluid volumes in humans. Am J Physiol 1984;247:F632-F636.
23. van der Hoorn FAJ, Boomsma F, Man in 't Veld AJ, Schalekamp MA. Determination of catecholamines in human plasma by high-performance liquid chromatography: comparison between a new method with fluorescence detection and an established method with electrochemical detection. J Chromatogr 1989;487:17-28.
24. Boer P, Sleumer JH, Spriensma M. Confirmation of the optimal pH for measuring renin activity in plasma. Clin Chem 1985;31:149-50.
25. van der Hoorn FAJ, Boomsma F, Man in 't Veld AJ, Schalekamp MADH. Improved measurement of urinary catecholamines by liquid-liquid extraction, derivatization, and high-performance chromatography with fluorimetric detection. J Chromatogr 1991;563:348-55.
26. Weidmann P, Maxwell MH, Lupu AN, Lewin AJ, Massry SG. Plasma renin activity and blood pressure in terminal renal failure. N Engl J Med 1971;285:757-62.
27. Kailasam MT, Parmer RJ, Cervenka JH, et al. Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension. Hypertension 1995;26:143-9.
28. Faber JE, Brody MJ. Afferent renal nerve-dependent hypertension following acute renal artery stenosis in the conscious rat. Circ Res 1985;57: 676-88.
29. Campese V, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 1995;25:878-82.
30. Ye S, Ozgur B, Campese VM. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int 1997;51:722-7.
31. Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol 1992;262:E763-E778.
32. Williams JL, Barnes KL, Brosnihan KM, Ferrario CM. Area postrema: a unique regulator of cardiovascular function. News Physiol Sci 1992;7:30-4.
33. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche J-L. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease: comparative effects of ACE inhibition and calcium-channel blockade. Circulation 1994;90:2786-96.